A modern clinic for at-home treatments
(857) 240-1080
Holiday Sale! Get started today for only
$49 $4.99
Written and prepared by:
Marc Emmenegger, Chryssa Zografou, Yile Dai, Laura R. Hoyt, Ravindra Gudneppanavar, Andra Chincisan, Hubert Rehrauer, Falko J. Noé, Natalia Zajac, Georg Meisl, Matthias M. Schneider, Hang Nguyen, Katja Höpker, Tuomas P. J. Knowles, Mireia Sospedra, Roland Martin, Aaron M. Ring, Stephanie Leeds, Stephanie C. Eisenbarth, Marie E. Egan, Emanuela M. Bruscia, Adriano Aguzzi
Explore how the Cystic Fibrosis Transmembrane Regulator (CFTR) controls tolerogenic responses to food allergens in mice and humans. This study reveals that individuals with cystic fibrosis (CF) develop IgG4 antibodies against peanut allergens without suffering from peanut allergies, suggesting a unique immune response. The findings highlight CFTR's role in regulating food allergen tolerance, providing insights into potential therapeutic strategies for food allergies.
Study shows CFTR regulates tolerogenic responses to food allergens, influencing IgG and IgE levels in mice and humans.
Cystic fibrosis patients exhibit IgG4 but not IgE responses to food allergens, suggesting a unique immune profile.
Research reveals CFTR's role in cytokine regulation and epithelial barrier function, promoting food allergen tolerance.
Study compares antibody profiles in cystic fibrosis patients and healthy controls, highlighting distinct immune responses.
Findings suggest CFTR influences peanut allergen desensitization, with cystic fibrosis patients showing unique antibody responses.
Research suggests new approaches for allergy treatments in cystic fibrosis patients based on CFTR's role in immune regulation.
Insurance covers clinical consultations.
Subscription fee (from $59/month not billed to insurance) covers immunotherapy, shipping & related costs.